Cytex Therapeutics, Inc.

State Juristiction
DE
Date of Incorporation
2006-07-21
CIK
1943908
Legal Form
Corporation
Offering via StartEngine Capital LLC aka StartEngine
  • As of 2022-10-26, raising $10,000.00-$1,070,000.00 via 5,000+ of Series B-CF Non-Voting Common Stock at $2.00 by 2023-01-24Costing 13% in cash and 2% in equity
Filing date2022-10-26
Current employees8
Act received most recent fiscal year$66,611.00
Act received prior fiscal year$197,422.00
Cash equi most recent fiscal year$489,299.00
Cash equi prior fiscal year$267,208.00
Cost goods sold most recent fiscal year$1,263,476.00
Cost goods sold prior fiscal year$1,288,308.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$22,653.00
Net income prior fiscal year$40,442.00
Revenue most recent fiscal year$1,836,602.00
Revenue prior fiscal year$1,845,230.00
Short term debt most recent fiscal year$144,543.00
Short term debt prior fiscal year$233,574.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$626,138.00
Total asset prior fiscal year$480,707.00